This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kazuya Kanazawa, MD
Gunma-Ken, Japan

Tatsuya Aikawa, MD
Ibaraki-Ken, Japan

Fumio Tsuda, PhD
Tokyo, Japan

Hiroaki Okamoto, MD
Immunology Division Jichi Medical School Minamikawachi-Machi Tochigi-Ken 329-04, Japan

Arch Dermatol. 1996;132(11):1391-1392.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Hepatitis C virus (HCV) is known to induce various skin manifestations, most likely by the formation of circulating immune complexes.¹ Previously, we reported that HCV is closely associated with prurigo, which can be treated with interferon.² In an attempt to see if HCV infection is associated with other dermatologic manifestations, patients attending a dermatology clinic for the care of psoriasis were tested for antibody to HCV and HCV RNA.

During January 1994 and March 1995, 27 consecutive patients with psoriasis (16 men and 11 women) visited the dermatology clinic of the Isesaki Municipal Hospital, Gunma-Ken, Japan. None of the patients had been referred from other hospitals. Antibody to HCV was detected by the second-generation enzyme immunoassay in 9 (33%) of the 27 patients with psoriasis and antibody to synthetic HCV core peptides³ in 12 (44%). The frequency of antibody to HCV in the patients with psoriasis . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?